Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.658 USD | +2.86% | +1.22% | -11.75% |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Evolution of the average Target Price on Traws Pharma, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Traws Pharma, Inc.
HC Wainwright | |
Ladenburg Thalmann | |
Guggenheim |
EPS Revisions
- Stock Market
- Equities
- TRAW Stock
- Consensus Traws Pharma, Inc.